基本信息
浏览量:25
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Odete da Cruz e Silva (OCS) is Director of the Medical Sciences department at the University of Aveiro, was Coordinator of the Centre for Cell Biology from 2010-2015 and heads the Neuroscience and Signalling Group. Research areas include: Signal Transduction therapeutics, Protein Phosphorylation systems, Alzheimer's disease, Biomarker discovery, Neuronal Regeneration, Biomaterials in Neuroscience and Translational Research. OCS coordinates the pcb-Cohort (primary care based-Cohort); a group of almost 600 volunteers from the Aveiro region. The research group was responsible for creating the Portal for Family Members and Caregivers of Patients with Alzheimer’s Disease (2010-2015), for which they were awarded the Angelini University Award in 2011.
In the International front, OCS has been involved in 5 European Projects and Nationally in 17 projects (PI in 9). She is Associate Editor in the Journal of Alzheimer’s Disease, Editor in Frontiers in Aging Neuroscience and Advances in Biology. The work has resulted in over 150 publications and OCS has been recognized with prizes from the Astra Zeneca Foundation and the Gulbenkian Prize for stimulating research. Initiatives as an Entrepreneur include setting up a startup company (2CTech) for which she was awarded the prize ‘Concurso de Ideias da UATEC Empreende+’ in 2011 and is co-founder of Hack & Hustle and Axodynamics.
OCS cloned the first protein phosphatase (PP2A) at the University of Dundee in Scotland while working with Sir Philip Cohen. Other contributions to research included evaluating serum from patients with Systemic Lupus Erythematosus to identify autoantibodies and isolating the first clone for the human liver phenol/bilirubin: UDP-glucuronosyltransferase. The acquired knowhow was applied to Alzheimer’s disease upon moving to the Rockefeller University in New York to the laboratory of Paul Greengard, Nobel prize laureate for medicine in 2000. The work revealed for the first time that the phosphorylation state of the Alzheimer’s amyloid precursor protein (APP) could determine its processing and cellular fate.
In the year 2000 OCS established her research group at the University of Aveiro. Initial work focused on the molecular basis of Alzheimer’s disease and the group showed that protein phosphorylation can define not only processing but also intracellular protein targeting and ultimately contribute to the production of toxic Abeta fragments, which deposit in brains of patients with Alzheimer. Abeta aggregation studies were carried out, and showed that this peptide is highly relevant as a signalling molecule affecting protein phosphorylation, gene expression and cytoskeleton remodeling. A subsequent, Systems Biology approach was applied and the interactome for various protein phosphatases and the Alzheimer’s Precursor Protein (APP) were described as well as novel functional multimeric complexes. Many of these complexes contain protein phosphatase 1 and are regulated by the latter (i.e. APP:Fe65:PP1 and torsinA:LAP1:PP1). Results from some of these findings permitted work on other neuropathologies, like Parkinson’s disease and Torsion Dystonia. The observation that some of the protein studied are expressed/enriched in brain and testis promoted work in male infertility and cancer, always from a cell signalling perspective. A curious, previously undocumented, distribution of APP in sperm was described. This led to studying the neuron and the sperm in parallel. Subsequent studies have addressed the increasingly documented overlap between Alzheimer and Diabetes, from a clinical to a molecular perspective.
In the pre-clinical sector, the group offers the CSF-based neurochemical diagnosis of dementia and efforts are focusing on blood-based biomarkers. Several molecular candidates relevant to both diseases have emerged and are being pursued from a translational perspective and for their diagnostic and therapeutic potential.
Other research lines have evolved to address the advantages of biomaterials for diagnostic and therapeutic strategies and exploring chemical compounds for novel applications. These include MnSr-doped brushite bone cements to improve bone performance and how capacitive surfaces can stimulate osseointegration. Another research line on piezoelectric biomaterials addressed how electrically polarized PLLA platforms can promote neuritogenesis. On another front, work on fluorescent markers with large stroke’s shift for specific labelling and imaging led to an international patent for clinical applications of this compound.
In pedagogy OCS was responsible for designing and introducing at the University of Aveiro the Biomedical Sciences undergraduate degree, of which she was Director from 2006-2012, the Master’s degree in Molecular Biomedicine of which she was Director from 2009-2018, as well as Director of the Biomedicine Doctoral Programme from 2015-2018. More than 133 students have been supervised in the laboratory.
研究兴趣
论文共 186 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 3 (2024): 1584
Tânia Soares Martins,Maria Ferreira,Sandra Magalhães,Kevin Leandro, Luís P de Almeida,Jonathan Vogelgsang,Benedict Breitling,Niels Hansen,Hermann Esselmann, Jens Wiltfang,Odete A B da Cruz E Silva,Alexandra Nunes,
Journal of Alzheimer's disease : JADno. 3 (2024): 1157-1167
AGING BRAIN (2023): 100080-100080
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn